×
SARTORIUS EBITDA 2016-2025 | SARTF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
SARTORIUS ebitda from 2016 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
SARTORIUS EBITDA 2016-2025 | SARTF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
SARTORIUS ebitda from 2016 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$188.8B
Intuitive Surgical (ISRG)
$170.7B
IDEXX Laboratories (IDXX)
$51.6B
Edwards Lifesciences (EW)
$48B
Alcon (ALC)
$40.5B
IQVIA Holdings (IQV)
$32.5B
DexCom (DXCM)
$32.3B
Mettler-Toledo (MTD)
$27.2B
STERIS (STE)
$24.8B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.3B
Hologic (HOLX)
$15.2B
Penumbra (PEN)
$10.3B
Globus Medical (GMED)
$8.4B
Sysmex ADR (SSMXY)
$8.4B
Masimo (MASI)
$8.1B
Teleflex (TFX)
$5.7B
Glaukos (GKOS)
$5.4B
TransMedics (TMDX)
$4.1B
Integer Holdings (ITGR)
$3.9B
LivaNova (LIVN)
$3.1B
Veracyte (VCYT)
$2.4B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.3B
Artivion (AORT)
$2.1B
Elekta AB (EKTAY)
$1.9B
Nihon Kohden (NHNKY)
$1.9B
Integra LifeSciences Holdings (IART)
$1.2B
Pulse Biosciences (PLSE)
$1.1B
OPKO Health (OPK)
$1.1B